Philip Chang, MD

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

My clinical services include serving as a neuro-hospitalist at and as a regional telestroke neurologist for Northern California since 8/2018. I am involved with regional conferences to discuss potential PFO closures. Besides my current clinical duties, I am involved in local and regional efforts to improve delivery of acute stroke therapies to patients in the northern California Permanente Medical Group. I am involved in medical student and resident teaching. In addition, I am also involved in the implementation and usage of Ceribell, an EEG-headband to improve treatment times of status epilepticus. In addition, I am a member of the American Heart Association and the American Academy of Neurology.

Given the rocky trial history of both alteplase and thrombectomy in acute stroke care, I have had a great interest in trial design and application of clinical trials in acute stroke care. In this purpose, I am a reviewer for the stroke council in the American Stroke Association for the journal Stroke. In addition, I am a contributor of “Blogging Stroke”, an American Stroke Association to popularize and inform the community about recent advances in stroke, along with personal interpretations of recent major clinical trials in a contemporary and accessible manner to the millennial generation.

Publications

  • Published 11/8/2022

    Kharbanda RK, Moore JP, Lloyd MS, Galotti R, Bogers AJJC, Taverne YJHJ, Madhavan M, McLeod CJ, Dubin AM, Mah DY, Chang PM, Kamp AN, Nielsen JC, Aydin A, Tanel RE, Shah MJ, Pilcher T, Evertz R, Khairy P, Tan RB, Czosek RJ, Shivkumar K, de Groot NMS. Cardiac Resynchronization Therapy for Adult Patients With a Failing Systemic Right Ventricle: A Multicenter Study. J Am Heart Assoc. 2022 Nov 15; 11(22):e025121. PMID: 36346046.

    Read at: PubMed

  • Published 6/1/2020

    Wang K, Luo J, Yeh S, You B, Meng J, Chang P, Niu Y, Li G, Lu C, Zhu Y, Antonarakis ES, Luo J, Huang CP, Xu W, Chang C. The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer. Nat Commun. 2020 06 01; 11(1):2689. PMID: 32483206.

    Read at: PubMed

  • Published 1/1/2019

    Chang P, Bernstein RA. CURRENT Diagnosis & Treatment Neurology (John C.M. Brust ed.). Cerebrovascular Disease: Hemorrhagic Stroke. McGraw-Hill Education. 2019; 120-145.

  • Published 12/1/2018

    Chang P, Ruff I, Mendelson SJ, Caprio F, Bergman DL, Prabhakaran S. The 2CAN Score. Stroke. 2018 12; 49(12):2866-2871. PMID: 30571426.

    Read at: PubMed

  • Published 4/13/2017

    Chang P, Prabhakaran S. Recent advances in the management of acute ischemic stroke. F1000Res. 2017; 6. PMID: 28491278.

    Read at: PubMed

View All 14 Publications:   View Full Profile in BUMC

Websites

Education

  • Northwestern University School of Medicine, MD
  • Northwestern University, BA

View all profiles